Hiroyuki Nakanishi

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroaki Matsumoto, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Hayakawa, Yutaka Yasui, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Taisei Keitoku, Tsubasa Nobusawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Masayuki Kurosaki, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma. Cancers 14 (14) (2022)
Shun Kaneko, Masayuki Kurosaki, Kaoru Tsuchiya, Yutaka Yasui, Yuka Hayakawa, Kento Inada, Yuki Tanaka, Shun Ishido, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Hiroyuki Nakanishi, Namiki Izumi
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma. PloS one 17 (3) (2022)

Hiroyuki Nakanishi.css-eqlu8i{font-size:small;padding-left:4px;}